Our Portfolio

We help our clients to power their growth by offering bespoke solutions to their needs, through a wide range of products and services across asset classes.

Our Investment Programs

PROGRAMVINTAGEINVESTMENT STRATEGYMARKET SEGMENT % BY AREALINK
CAM II2000Global Buyout & GrowthLarge & Mid Cap MarketEurope c. 50% North America c.50%More
CAM III2004Global Buyout & GrowthLarge & Mid MarketEurope c. 50% North America c.40% Asia / RoW c.5%More
Altamar Buyout Europa FCR2005European Global BuyoutLarge & Mid MarketEurope 85% Usa Row 15%More
CAM Evergreen2005Global BuyoutLarge & Mid MarketEurope c.75% North America c.20% Asia / RoW c.5%More
Altamar Buyout Global II & III FCR2006/07Global BuyoutLarge, Mid & SmallEurope 60% Usa Row 40%More
CAM IV2007Global Buyout & GrowthLarge & Small Cap MarketGlobalMore
Altamar Secondary Opportunities IV FCR2009Global Buyout (Secondary Market)SecondaryMore
Altamar V Private Equity Program FCR2011/12Global Buyout / Growth Emerging Markets / Special OpportunitiesUpper-Mid-Low / Middle MarketEurope 30%-40% USA 50%-60% Asia 5%-15%More
CAM V2013Global BuyoutLarge & Mid MarketEurope c.75% North America c.20% Asia / RoW c.5%More
Altamar VI Emerging Markets Private Equity FCR2013/14Buyout Emerging MarketsUpper-Mid-Low / Middle MarketMarket Asia 50%-60% Latam 40%-50%More
Altamar Secondary Opportunities VII & VII BP FCR2013/14Global Buyout (Secondary Market)SecondaryMore
Altamar Global Private Equity Program VIII & VIII BP FCR2014/15Global Buyout / Growth Emerging Markets / Special OpportunitiesUpper-Mid-Low Middle MarketEurope 30-40% USA 30-40% Asia/Latam 10-15% Special Opp 15-20% Sec/co-inv hasta 30%More
Altamar Global Secondaries IX FCR2016Global BuyoutSecondaryEurope / USA / Emerging MarketsMore
Altamar X Global Private Equity Program FCR2018Global BuyoutUpper-Mid-Low Middle MarketEurope / USA / Emerging MarketsMore
ACP Secondaries 42019Global BuyoutSecondaryEurope / USA / EmergentsMore
CAM VI2020Global Buyout (Middle Market)Middle MarketEurope c.50% North America c.30% Asia / RoW c.20%More
ACP Multiactivo I, FCR2021Global Buyout / GrowthLarge, and fundamentally Upper-Mid-Low Middle MarketEurope / USA / Emerging Markets
More
ACP – Private Equity 7, FCR2022Global Buyout / GrowthLarge, and fundamentally Upper-Mid-Low Middle MarketEurope: 25-30%
USA: 25-30%
Emerging Markets: 5-10%
Special Opp: 5-10%
Sec/Co-inv: up to 20%-30%
More
ACP Secondaries 52023Global BuyoutSecondaryEurope / USA / EmergentsMore
PROGRAMVINTAGEINVESTMENT STRATEGYMARKET SEGMENTLINK
Galdana Ventures I FCR2016Venture Capital GlobalEarly Growth & GrowthMore
Galdana Ventures II FCR2018Venture Capital GlobalEarly Growth & GrowthMore
Galdana Ventures III FCR2021Venture Capital GlobalEarly Growth & GrowthMore
PROGRAMVINTAGEINVESTMENT STRATEGYMARKET SEGMENTLINK
Altan I Inmobiliario Global FIL2007/08Private Equity Real Estate GlobalLarge, Mid & SmallMore
Altan II Inmobiliario Global FIL2007/08Private Equity Real Estate GlobalLarge, Mid & SmallMore
Altan III Global FIL2013/14Private Equity Real Estate GlobalLarge, Mid & SmallMore
Altan IV Global I.I.C.I.I.C.I.L.2017/18Private Equity Real Estate GlobalLarge, Mid & Small More
Altan V Global I.I.C.I.I.C.I.L.2021Private Equity Real Estate GlobalLarge, Mid & Small More
ACP Real Assets Sustainable Megatrends FCR2021Real Assets GlobalLarge, Mid & SmallMore
PROGRAMVINTAGEINVESTMENT STRATEGYMARKET SEGMENTLINK
GIF2012Global InfrastructureCore/Core-Plus/Value-Added and multi-sector focusMore
Altamar Infrastructure Income I F.C.R.2015Global InfrastructureCore-Plus / Value-Added with a multisector focusMore
Altamar Infrastructure Income II F.C.R.2019Global InfrastructureCore-Plus / Value-Added with a multisector focusMore
GIF II2021Global InfrastructureCore/Core-Plus/Value-Added and multi-sector focusMore
Altamar Infrastructure Income III F.C.R.2023Global InfrastructureCore-Plus/ Value-Added with multisector focusMore
PROGRAMVINTAGEINVESTMENT STRATEGYMARKET SEGMENTLINK
CAM Life Sciences2006Global Life Science Venture CapitalSmall MarketMore
Alta Life Sciences Spain I FCR2016Investments in Biotechnology, Biopharma, Medical Devices / Diagnostics, Genomics and Digital HealthAll development stages: Seed, Series A, Series B y Series C,D,E… More
CAM HCO2018Global Life Science VC & GrowthSmall MarketMore
PROGRAMVINTAGEINVESTMENT STRATEGYMARKET SEGMENTLINK
Altamar Private Debt I I.I.C.I.I.C.I.L.2017Private debtSenior Loans for Mid Market CompaniesMore
Altamar Private Debt III I.I.C.I.I.C.I.L.2021Private debtCombination of direct lending managers with opportunistic credit managersMore